Maiken Keson-Brookes, See Remarks at Mural Oncology plc (MURA), sold 2,555 shares at $3.27 ($8K) on 2024-12-23, disclosed to the SEC on 2024-12-26.
Scheduled sale ($8k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MURA | SELL | 2025-03-05 | $9K | — | Filing → |
| MURA | SELL | 2024-07-18 | $7K | — | Filing → |
| RUBY | SELL | 2022-02-01 | $18K | — | Filing → |